LOGIN
DOWNLOAD
ESPAÑOL
RCT
ACE Report #14082
Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis
How to Cite
OrthoEvidence. Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis. ACE Report. 2021;131(1):2. Available from: https://myorthoevidence.com/AceReport/Report/14082
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis: A Randomized Active-Controlled Clinical Trial
Evid Based Complement Alternat Med. 2021; 2021: 5596892.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty-eight patients with knee osteoarthritis were randomized to receive 1 month of Harpagophytum procumbens treatment (n=18) or 10 days of daily meloxicam (n=20). Outcomes of interest included pain on a Visual Analog Scale (VAS), the Oxford Knee Scale (OKS) score, and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) score. Outcomes were assessed at 2, 4 and 8 weeks follow up...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MOREFor Reprints and Permissions, click here
Please Login or Join to leave comments.